Skip to main content
Clinical Trials/IRCT20200607047675N1
IRCT20200607047675N1
Completed
Phase 3

A prospective randomized controlled trial comparing the effectiveness of traditional medicine combination based on the Ferula assa-foetida gum - Tragacanth with moderate to severe Coronavirus disease (COVID-19) compared to standard treatment

Mashhad University of Medical Sciences0 sites122 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Mashhad University of Medical Sciences
Enrollment
122
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • PCR confirmed
  • diagnostic chest CT scan
  • Consent for voluntary participation
  • Hospitalization

Exclusion Criteria

  • Patients with end stage heart failure
  • Recent cardiac intervention (less than 2 months): coronary angioplasty, ICD, CABG, Valvuloplasty or replacement
  • Pulmonary fibrosis or advanced COPD
  • End stage kidney or liver disease
  • Pregnant or lactating ladies
  • Patients on immunosuppressive therapy
  • Active tuberculosis
  • Active hepatitis
  • The critical stage of COID19

Outcomes

Primary Outcomes

Not specified

Similar Trials